Reactions 1916, p380 - 23 Jul 2022 1

Rosuvastatin S

Elevated ALT level: case report

In a retrospective cohort study of 627 patients, admitted from 01 January 2017 to 31 December 2018 at a heart hospital in Qatar,
a patient [age and sex not stated] was described, who experienced elevation of ALT during treatment with rosuvastatin for acute
coronary syndrome (ACS). The patient, who had ACS, started receiving oral rosuvastatin [dose not stated] once daily. Subsequently,
the patient experienced elevation of ALT >3 times the upper limit of normal secondary to rosuvastatin [duration of treatment to
reaction onset and outcome not stated].
Rahhal A, et al. A Comparative Study of High-intensity Rosuvastatin Versus Atorvastatin Therapy Post-acute Coronary Syndrome Using Real-world Data. Current Problems
in Cardiology 47: 100956, No. 7, Jul 2022. Available from: URL: http://www.elsevier.com/inca/publications/store/6/2/3/2/8/9/index.htt 803686328

0114-9954/22/1916-0001/$14.95 Adis © 2022 Springer Nature Switzerland AG. All rights reserved Reactions 23 Jul 2022 No. 1916